Verminderte Knochendichte und Veränderungen im ...

Literaturverzeichnis
208. Yano K, Tsuda E, Washida N, et al. Immunological characterization of circulating
osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in
postmenopausal women with osteoporosis. J Bone Miner Res. 1999;14:518-27.
209. Yazici AE, Bagis S, Tot S, Sahin G, Yazici K, Erdogan C. Bone mineral density
in premenopausal women with major depression. Joint Bone Spine. 2005;72:540-3.
210. Yazici KM, Akinci A, Sutcu A, Ozcakar L. Bone mineral density in
premenopausal women with major depressive disorder. Psychiatry Res. 2003;117:271-5.
211. Yehuda R. Am J Psychiatry. 1993;150:83-86.
212. Yehuda R, Golier JA, Halligan SL, Meaney M, Bierer LM. The ACTH response
to dexamethasone in PTSD. Am J Psychiatry. 2004;161:1397-403.
213. Yirmiya R, Goshen I, Bajayo A, et al. Depression induces bone loss through
stimulation of the sympathetic nervous system. Proc Natl Acad Sci U S A.
2006;103:16876-81.
214. Young EA, Haskett RF, Murphy-Weinberg V, Watson SJ, Akil H. Loss of
glucocorticoid fast feedback in depression. Arch Gen Psychiatry. 1991;48:693-9.
215. Zanarini MC, Frankenburg FR, Dubo ED, et al. Axis I comorbidity of borderline
personality disorder. Am J Psychiatry. 1998;155:1733-9.
216. Zautra AJ, Yocum DC, Villanueva I, et al. Immune activation and depression in
women with rheumatoid arthritis. J Rheumatol. 2004;31:457-63.
217. Zheng D, Macera CA, Croft JB, Giles WH, Davis D, Scott WK. Major depression
and all-cause mortality among white adults in the United States. Ann Epidemiol.
1997;7:213-8.
218. Ziegler R, Kasperk C. Glucocorticoid-induced osteoporosis: prevention and
treatment. Steroids. 1998;63:344-8.
219. Zimmerman M, Mattia JI. Differences between clinical and research practices in
diagnosing borderline personality disorder. Am J Psychiatry. 1999;156:1570-4.
79